Amgen (AMGN) Target Lifted to $170 at Piper Jaffray Ahead of Tonight's Q3 Print
Tweet Send to a Friend
Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on Amgen (NASDAQ: AMGN) while boosting his price target to $170.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
